Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Mark Froimson currently holds 10,891 shares of Pacira Pharmaceuticals, Inc. (PCRX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Mark Froimson has been a net seller of PCRX stock. They have purchased $19.9K and sold $123.3K worth of shares.
Mark Froimson's most recent insider trade was on Jun 10, 2026, when they sold 10,891 shares at $0.00 per share.
Mark Froimson serves as Executive at Pacira Pharmaceuticals, Inc. (PCRX). They have executed 17 insider transactions totaling $143.2K over their tenure at the company.
Mark Froimson holds the position of Executive at Pacira Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 9 years and currently hold a stake valued at $0.
Mark Froimson has shown a selling trading pattern, with $19.9K in total purchases and $123.3K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Mark Froimson was on May 9, 2022, when they sold $59.4K worth of PCRX shares. This transaction involved 1,000 shares at $59.37 per share.
Mark Froimson currently owns 10,891 shares of Pacira Pharmaceuticals, Inc. (PCRX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Mark Froimson's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Mark Froimson has 17 Form 4 filings on record as an insider at Pacira Pharmaceuticals, Inc..
Set alerts for Mark Froimson and 40,000+ other insiders.